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Abstract
Rapid antigenic evolution enables the persistence of seasonal influenza A and B viruses in
human populations despite widespread herd immunity. Understanding viral mechanisms
that enable antigenic evolution is critical for designing durable vaccines and therapeutics.
Here, we utilize the primerID method of error-correcting viral population sequencing to
reveal an unexpected role for hemagglutinin (HA) glycosylation in compensating for fitness
defects resulting from escape from anti-HA neutralizing antibodies. Antibody-free propaga-
tion following antigenic escape rapidly selected viruses with mutations that modulated
receptor binding avidity through the addition of N-linked glycans to the HA globular domain.
These findings expand our understanding of the viral mechanisms that maintain fitness dur-
ing antigenic evolution to include glycan addition, and highlight the immense power of high-
definition virus population sequencing to reveal novel viral adaptive mechanisms.
Author summary
Seasonal influenza A viruses (IAV) cause tens of thousands of deaths and tens of billions
of dollars in economic costs every year in the U.S. alone, despite widespread pre-expo-
sure and vaccination. IAV persists within the human population by evading herd immu-
nity through the continual accumulation of immune escape substitutions in a process
known as antigenic drift. Unfortunately, the specific mechanisms that facilitate IAV
antigenic drift remain unclear, making it difficult to design more efficacious, escape-
proof vaccines. Here, we used a high-definition population sequencing approach to
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006796 January 18, 2018 1 / 19
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Kosik I, Ince WL, Gentles LE, Oler AJ,
Kosikova M, Angel M, et al. (2018) Influenza A
virus hemagglutinin glycosylation compensates for
antibody escape fitness costs. PLoS Pathog 14(1):
e1006796. https://doi.org/10.1371/journal.
ppat.1006796
Editor: Paul G. Thomas, St. Jude Children’s
Research Hospital, UNITED STATES
Received: April 25, 2017
Accepted: December 7, 2017
Published: January 18, 2018
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced,
distributed, transmitted, modified, built upon, or
otherwise used by anyone for any lawful purpose.
The work is made available under the Creative
Commons CC0 public domain dedication.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: All work funded directly by US gov0t. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
understand how IAV tolerates the accumulation of immune escape substitutions during
antigenic drift without losing fitness. We found that the virus rapidly acquired N-linked
glycan structures on the hemagglutinin (HA) protein following escape from a panel of
neutralizing antibodies. Glycosylation of HA alleviated the deleterious effects of immune
escape substitutions on interactions with host cell receptors. These results expand our
understanding of the mechanisms that facilitate IAV immune evasion, and highlight the
immense power of high-definition virus population sequencing to reveal novel viral
adaptive mechanisms.
Introduction
Influenza A virus (IAV) persists in human populations by continuously evolving to escape
herd immunity. Protective immunity is predominantly mediated by neutralizing antibodies
(Abs) specific for the viral surface glycoprotein hemagglutinin (HA). HA mediates both target
cell attachment, by binding terminal sialic acids (SA) on cellular membrane components, and
fusion between viral and cellular membranes following virion internalization. Neutralizing
Abs mainly target the five highly variable immunodominant antigenic sites on the globular
head domain of HA, blocking either HA-mediated attachment or fusion [1–4]. Viruses can
escape neutralization by amino substitutions in HA that reduce antibody affinity and/or func-
tion. The fitness costs imposed by Ab escape, and the mechanisms by which the virus compen-
sates remain poorly understood, yet play a central role in governing HA antigenic evolution
[5,6].
Influenza virus escapes from neutralizing antibody via a number of defined mechanisms
involving HA mutations. The simplest is an amino acid substitution in a cognate epitope that
diminishes antibody affinity [2]. Less commonly, distant substitutions can affect antibody
binding via allosteric effects on antibody access to its epitope [7–9]. Amino acid substitutions
in the sialic acid receptor site, or other regions of the globular domain that increase affinity for
cellular SA receptors, enable Ab-escape by shifting the binding equilibrium towards virus
binding to cells versus antibody [10–13]. The most drastic alterations in overall antigenicity
typically result from amino acid substitutions that create a N-linked glycosylation site in the
globular domain, as the attached glycan can sterically block the binding of Abs to multiple
sites [5,14–19].
The ability of viruses to exploit these escape routes is limited by their costs to viral fitness.
The sialic acid receptor binding site is nestled among the immunodominant antigenic sites,
and escape substitutions often alter viral fitness by changing HA receptor binding avidity.
Amino acid substitutions that change the net charge of the globular domain typically alter cell
binding avidity [13,20]. We previously demonstrated that selection of substitutions that add
N-linked glycosylation sites within the globular domain to escape antibody neutralization
often reduces receptor avidity [5]. Receptor avidity and HA antigenicity are thus intimately
linked, and must be continuously balanced to maintain fitness during antigenic evolution
[13,21].
Here, we use the primerID method for error-correcting virus population sequencing to
reveal a surprising new role for N-linked glycosylation in facilitating IAV immune escape.
Beyond its canonical role in blocking Ab binding, we show that glycosylation can also com-
pensate for fitness costs imposed by escape substitutions elsewhere on HA, thus increasing the
viability and subsequent emergence potential of Ab-escape variants.
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Results
HA Ab escape mutations reduce viral fitness in the absence of Ab pressure
We previously modeled IAV antigenic evolution by sequentially selecting for virus escape
from different mouse anti-HA monoclonal Abs (mAbs) under over-neutralizing conditions
using the allantois-on-shell (AOS) system [21]. Twelve rounds of mAb escape by PR8 yielded a
virus (SV12) carrying twelve amino acid substitutions in HA that collectively mediated near
total escape from polyclonal serum raised against PR8 in mice, guinea pigs or chickens. When
propagated in embryonated chicken eggs, PR8 and SV12 reached similar titers in the absence
of Ab pressure, suggesting that the selected constellation of escape mutations imposed minimal
fitness costs on the virus.
An alternative possibility that we did not examine in detail is that the accumulation of anti-
genic escape substitutions imposed significant costs, but strong selection for compensatory
mutations or reversions in SV12 rapidly restored fitness during the initial rounds of SV12
expansion in eggs; the original SV12 isolate had been expanded 2–3 times in the absence of
antibody in embryonated chicken eggs after the 12th sequential selection in the AOS system
[21]. To test this possibility, we generated a recombinant PR8 clone carrying the consensus
SV12 HA gene segment and compared the ability of WT PR8 and the consensus SV12 clone to
replicate in eggs (Fig 1). This revealed that antigenic escape substitutions present within SV12
HA imposed significant fitness costs (greater than 10-fold decreased titer) when the virus pop-
ulation had limited time to recover fitness via mutational compensation.
High resolution examination of IAV mutational spectra using primerID
sequencing
Compensatory mutations that increased the fitness of SV12 may not have been identified with
conventional Sanger sequencing if multiple variants were selected that collectively were a sig-
nificant proportion of the population, but that individually remained below the wild-type
SV12 consensus frequency at each codon. To identify compensatory mutations or reversions
in HA that potentially emerged following sequential antigenic escape, we used the primerID
method for error-correcting virus population sequencing to identify minor sequence variants
that emerged during the limited expansion passaging of SV12 [22,23].
PrimerID sequencing is based on tagging individual viral cDNAs with random unique
sequence barcodes during reverse transcription [22,23]. These barcodes are maintained
through downstream PCR and sequencing steps and are used to assemble all sequencing reads
derived from a single cDNA sequence. This permits consensus-based reconstruction of the
original cDNA sequence, enumeration of actual viral genomes sampled, and analysis of linkage
between specific mutations within reads. Importantly, primerID lowers the background
sequencing error rate of the Illumina platform 10-100-fold (to 10−3–10−4 non-consensus
events/nt), by correcting the high-frequency PCR and base-calling errors that occur during
standard next-generation sequencing. PrimerID can also correct for variant frequency skewing
due to PCR resampling imbalance [22,23].
To precisely quantify the advantages conferred by primerID sequencing over shotgun
sequencing approaches in the context of IAV population sequencing, we directly compared
results obtained with the primerID method to those obtained by shotgun sequencing, as ana-
lyzed through the ViVan pipeline [24]. Variant calls with a moderately high frequency (>10−3)
show consistent results whether an amplicon/primerID or a shotgun sequencing approach
were used (S1 Fig); however, evaluating variant frequencies in the range of 10−4 to 10−3 shows
that primerID gives a higher signal to background noise ratio compared to shotgun
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sequencing (S2 Fig). The noise reduction of primerID consensus reads compared to unmerged
amplicon reads ranges from 9.2-fold to 18.9-fold (S1 Table). Similarly, the background noise
level, estimated by the median combined minor allele frequency (MAF) in primerID is about
3-10x10-5, which is 4.5 to 12-fold lower than background in shotgun sequencing (S2 Table).
Altogether, primerID allows for more conservative variant calling, and likely more accurate
estimations of variant frequencies, than algorithm-based error correction approaches [24,25].
PrimerID population sequencing reveals the rapid emergence of
compensatory variants following antigenic escape
To identify emergent HA variants within an approximately 143 a.a. region (115 to 258) that
encompassed the receptor binding pocket and most of the SV12 substitutions in the original
expanded SV12 virus stock, we performed paired-end sequencing of primerID libraries on the
Illumina MiSeq platform and analyzed data using a custom software pipeline. Sequencing
revealed amino acid substitutions at 7 sites that emerged at frequencies of>0.1% during 2–3
passages of SV12. These substitutions were (including their frequencies) K123N (1.7%),
K123E (1.1%), N133T (25%), N133S (8%), K144N (9%), K144E (0.5%), N145D (0.3%), K174E
(0.3%), K222T (0.17%), and G225D (3.7%) (all H3 HA numbering) (Fig 2A). Linkage analysis
Fig 1. Fitness tradeoff associated with the accumulation of antigenic escape substitutions in HA. Growth of plaque
purified biological clones of PR8 WT and SV12 was compared in eggs. Eggs were infected in triplicate with 500
TCID50 of the indicated virus. 48 hours later, viral loads in allantoic cavities were titered by TCID50 assay.
https://doi.org/10.1371/journal.ppat.1006796.g001
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revealed that substitutions at positions K123, N133, K144, K145, and G225 represented distinct
variants (S2 Table), and thus collectively made up approximately 50% of the population of the
SV12 stock.
Each substitution was observed at sites with potential functional roles in SV12 (Fig 2B).
Substitutions at two SV12-defining sites were observed: G225D was a reversion to the PR8
wild-type amino acid identity, while the most abundant substitution at N145 was D (0.3%),
rather than the PR8 wild-type S (0.01%). The other substitutions (K123N/E, N133T/S, K144N/
E, K174E, and K222T) were at new sites, but were adjacent to SV12-defining sites or rimmed
the receptor binding site (Fig 2B). Thus, a combination of forward mutations and reversions
rapidly emerged on the SV12 background following antigenic escape.
The addition of N-linked glycans to HA can compensate for the fitness
costs of antigenic escape
Three of the amino acid substitutions that emerged in the original expanded SV12 virus stock
(K123N, N133T, and K144N) created new potential N-linked glycan sites (PNGS) within the
HA sequence (at positions 123, 131 and 144, respectively). To determine whether these substi-
tutions indeed affected the glycosylation status of virion-associated HA[26], we introduced
each substitution individually into the recombinant consensus SV12 HA background
(rSV12-HA) and rescued viruses carrying the 7 other gene segments from WT PR8 by reverse
genetics. We generated purified, detergent-disrupted virus preparations of rSV12-HA, rSV12
(K123N)-HA, rSV12(N133T)-HA, and rSV12(K144N)-HA and digested with either Endo H
(cleaves mannose-rich N-linked glycans, but not complex N-linked glycans) or PNGase F
(cleaves all N-linked glycans). We compared the migration of digested and undigested HA on
a denaturing gel by immunoblotting (Fig 3A). All three compensatory PNGS clearly slowed
the migration of undigested, but not PNGase F-digested, HA on the gel, demonstrating that
each mutation results in the addition of a glycan chain to virion-associated HA.
We next tested whether compensatory glycosylation site additions increased the replicative
capacity of rSV12-HA in multi-step growth assays in eggs (Fig 3B). The impact of K144N on
Fig 2. Identification of variants that emerge on the SV12 background after passage in eggs in the absence of antibody. (A) Amino acid variant
frequencies within SV12 HA following limited passage in eggs, as determined by primerID sequencing. Red and black data points represent frequencies
obtained from two stocks separately expanded one time in eggs prior to sequencing. Amino acid positions with>0.1% variability (dashed line) in both
stocks are labeled with the most abundant substitution at the position. Codons 184–186 were not captured by sequencing. (B) HA structure (PDB
1RU7) with the SV12-defining substitutions (red) and emerging amino acid substitutions (labeled in 2A) (blue) highlighted. The black stick model
represents sialic acid situated in the receptor binding pocket.
https://doi.org/10.1371/journal.ppat.1006796.g002
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titer was marginal, but K123N and N133T both resulted in 10–100 fold higher viral titers com-
pared with parental rSV12-HA virus by 36 hpi, demonstrating a clear role for each of these gly-
cosylation site additions in restoring fitness in eggs following SV12 antigenic escape.
Glycan addition partially restores wild-type receptor binding
characteristics following antigenic escape
A clue to how these glycan additions restore SV12 fitness came from their close proximity to
the HA receptor binding pocket (Fig 2B). We hypothesized that the glycans modulate HA
receptor binding avidity, correcting for detrimental effects of escape substitutions. To test this,
we compared the association (Kon) and dissociation (Koff) rates of purified WT PR8,
rSV12-HA, rSV12(K123N)-HA, rSV12(N133T)-HA, and rSV12(K144N)-HA virion preps
binding to the model sialic acid receptor 3-SLN using bio-layer interferometry (BLI) (Fig 4,
Table 1). rSV12-HA exhibited a 3-fold increase in binding avidity, compared with WT HA.
The addition of the K123N, and N133T substitutions to SV12 HA altered binding constants
toward WT levels, consistent with our hypothesis. The K144N substitution reduced binding
avidity to a much greater degree than K123N or N133T, resulting a 2-fold decrease in avidity
Fig 3. Characterization of compensatory glycan additions. (A) Western blot comparison of HA glycosylation mutants following endoglycosidase
treatment. Treatment 1 = undigested, treatment 2 = Endo H digested, treatment 3 = PNGase digested. (B) Growth comparison of PR8, SV12, and SV12
plus individual compensatory mutations in eggs. Eggs were inoculated with 500 TCID50, and viral loads within allantoic cavities were assessed by TCID50
assay at the indicated time points.
https://doi.org/10.1371/journal.ppat.1006796.g003
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Fig 4. Bio-layer interferometry comparison of binding properties of WT, SV12 and SV12-N133T. To measure
binding properties of WT PR8, SV12, and the compensatory glycan addition mutant N133T, we bound biotinylated
3’SLN to sensor at different concentrations, and measured the Kon and Koff of intact purified virions in the presence
Epistatic glycosylation
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relative to WT HA. This effect may have crossed a line beyond the beneficial effects of K123N
and N133T, resulting in a detrimental loss of binding avidity (compared with WT) that may
explain the comparatively slower growth kinetics of the K144N variant (Fig 3B).
Similar repertoires of compensatory mutations emerge during independent
experiments
To determine the reproducibility (and potentially the predictability) of the compensatory
mechanisms that we observed, we repeated the passage experiment using recombinant, reverse
genetics-derived versions of either WT PR8 or SV12-HA (rSV12-HA) virus as the parental
virus. We generated each virus in 293T cells from transfected plasmids and then passaged each
virus in triplicate in chicken eggs, using a dose of 104 EID50 (based on allantois-on-shell infec-
tivity) to initiate each passage. We harvested each passage at 16 hours post-infection (h.p.i.) to
minimize defective interfering particle formation. After the third passage, we sequenced the
entire HA coding region of all six passaged populations, along with the parental seed stocks,
using an optimized primerID protocol, (see Methods). To overcome the sequence read length
limitations of the Illumina Miseq platform (<550nt read length limit), we used four amplicons
to cover the entire HA coding region.
Both SV12 and PR8 (WT) parental populations harbored numerous missense mutations at
frequencies above background in HA (Fig 5A). Five such mutations resulted in amino acid
substitutions that were present in the WT PR8 parental population at frequencies over 0.1%,
with a K123T substitution dominant at 2.5% (Fig 5B). Four of the WT variants likely emerged
due to stochastic genetic drift resulting from bottlenecking during the rescue process, as indi-
cated by minimal change in frequency by passage 3 [27]. One variant enriched in the WT
parental population, K174E, increased slightly in frequency in all three passage lines, and may
represent a tissue culture adaptive variant as it was also present in the parental rSV12-HA pop-
ulation. No other variants exhibited a consistent pattern of emergence during passaging of the
WT populations.
By contrast, the parental rSV12-HA population carried nearly three times as many missense
mutations (14 vs. 5) at frequencies >0.1% (Fig 5C), primarily located in the globular domain
of HA. Only K174E was also present in the WT parental population. Five of the 14 variants
increased or were maintained at high frequency during passaging in all three SV12 popula-
tions: N133T, T136S, K144E, N145D, and G225D (Fig 5D). Of these, N133T exhibited the
most dramatic increase in frequency and approached fixation in all three passage lines. Strik-
ingly, four of the five variants carried substitutions at residues that had elevated variant
and absence of the NA inhibitor oseltamivir, respectively. We fit two-phase (association then dissociation) nonlinear
regression curves based on the average of 2–3 experiments.
https://doi.org/10.1371/journal.ppat.1006796.g004
Table 1. Bio-layer interferometry analysis of HA compensatory glycans.
3’SLN Kon [nM
-1.ms-1] 3’SLN Koff [μs-1] 3’SLN Apparent KD [pM] 3’SLN R2
PR8 8.36±0.6 8.56±3.55 1.02±0.58 0.98
K123N 14.38±1.36 8.34±1.36 0.44±0.24 0.99
N133T 13.53±1.14 10.62±2.52 0.8±0.25 0.98
K144N 4.56±0.02 9.59±2.18 2.1±0.49 0.95
N133T/K144N 16.38±0.54 13.95±1.91 0.85±0.13 0.96
SV12 3.78±0.27 1.22±0.61 0.32±0.22 0.94
https://doi.org/10.1371/journal.ppat.1006796.t001
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frequencies in our first experiment: N133, K144, N145, and G225, indicating that compensa-
tion for antigenic escape can follow predictable genetic pathways under highly controlled
conditions.
Linkage analysis reveals near mutual exclusivity among compensatory
substitutions during passage
Emergence of an amino acid variant within a population may result from positive selection
driven by specific beneficial effects of the variant on fitness. Alternatively, the variant may be
neutral or deleterious but hitchhike with another variant under positive selection to attain
higher frequency. The potential for intragenic hitchhiking is high with IAV due to extreme rar-
ity of intragenic recombination during infection [28]. PrimerID sequencing allows the direct
quantification of linkage between amino acid positions present in individual viral cDNAs,
thereby defining the relative contributions of direct selection vs. hitchhiking in amino acid var-
iant emergence.
We assessed the extent of genetic linkage between the five high frequency variants that
emerged in all three rSV12-HA passage populations (N133T, T136S, K144E, N145D, and
G225D) (Fig 5D). Examination of linkage at passage 3 revealed that 4 of the variants, N133T,
K144E, N145D, and G225D, were mutually exclusive within single HA variants (with just a
handful of exceptions) (Fig 6A, S3 and S4 Tables). In contrast, T136S was only observed as
Fig 5. PrimerID sequencing of HA genes from recombinant WT and SV12-HA following passage. Recombinant PR8 (WT) and rSV12-HA (SV12) viruses
were rescued via reverse genetics. (A) Amino acid variant frequencies within WT (black) and SV12 HA (red) populations collected from rescue supernatants
without amplification, as determined by primerID sequencing. (B,C) Amino acid variant frequencies within WT (B) and rSV12-HA (C) populations
following three passages in eggs. For each population, all variants over 0.1% are colored to allow them to be visually distinguished. (D) Comparison of amino
acid variant frequencies within rSV12-HA populations before and after 3 passages in eggs. Passage 3 data represents mean +/- SD of three independent
passage lines. All amino acid numbering indicated on graphs A-C is from initiating methionine, not according to H3 system.
https://doi.org/10.1371/journal.ppat.1006796.g005
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paired with N133T. These results were consistent with the nearly mutually exclusive relation-
ships determined for the substitutions observed in the first sequencing experiment carried out
on the original SV12 stock (Fig 2, S2 Table).
These findings suggest that each emergent, mutually-exclusive substitution was selected
individually for its ability to compensate for the fitness defects of SV12, and that their combi-
nation in the same variant may substantially reduce fitness. The data, however, are also
Fig 6. Linkage analysis of high frequency variants that emerged during rSV12-HA passage. (A) Graphical
representation of genetic linkage between selected variants within the three parallel passage 3 rSV12-HA populations,
based on PrimerID sequencing. Node size is proportional to relative frequency of the indicated allele across the three
populations. Aqua nodes indicate parental amino acids and red nodes represent variant amino acids. Edges connect
pairs of amino acids that were linked in greater than 0.02% of all primerID consensus reads examined. (B) Multi-step
growth comparison of the indicated viruses in eggs.
https://doi.org/10.1371/journal.ppat.1006796.g006
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consistent with the predicted infrequent recombination within IAV genome segments and a
strong role for clonal interference in governing the emergence of beneficial alleles during
adaptation [29,30].
To test whether combining compensatory HA glycan additions decreases viral fitness, we
generated a N133T, K144N double mutant (rSV12(N133T, K144N)) using reverse genetics.
After confirming the double mutant did incorporate an additional glycan compared to the sin-
gle mutants by SDS-PAGE (S3 Fig), we examined its growth in eggs. The double mutant
achieved significantly higher titers than rSV12-HA, but lower than rSV12(N133T) (Fig 6B).
This result can be explained by the binding activity of the double mutant, which is comparable
to rSV12(N133T) based on BLI (Table 1). Together, these data suggest that clonal interference
rather than reduced fitness may be the primary explanation for the mutual exclusivity of com-
pensatory substitutions that we observe.
Discussion
IAV has persisted in humans despite widespread vaccination and infection, while vaccination
has driven other RNA viruses with similarly high mutation rates, such as measles virus and
poliovirus, to near-extinction. Understanding the specific features of IAV that enable effective
immune escape is critical for designing more effective vaccines and therapeutics.
Our findings reveal a novel role for glycosylation in viral immune evasion, independent of
its well-known steric effects on epitope shielding [14–19]. Previous studies clearly showed that
glycan addition generally impairs HA function while dramatically increasing fitness in the
presence of neutralizing antibodies [5]. Our results demonstrate that glycan addition can also
play the opposite role during antigenic drift: increasing the fitness of antigenic escape variants
by restoring optimal HA receptor interactions, even in the absence of antibody selective pres-
sure. This raises the intriguing possibility that both mechanisms contribute to the steady evolu-
tionary accretion of N-linked glycans within the globular domain observed during human
circulation of H1 and H3 viruses [17].
Importantly, the fact that we selected for glycan addition in the absence of Ab selection
does not diminish the profound effects that these glycans have on the antigenicity of HA. In
particular, the predominant variant selected, N133S/T, also emerged during the circulation of
seasonal H1N1 in humans, and has been demonstrated to have enormous effects on antigenic-
ity and sensitivity to neutralization [17]. These results highlight the self-perpetuating nature of
HA antigenic evolution. Hensley et al. found that infection of naïve hosts with antigenic escape
variants selected for compensatory mutations that were themselves antigenically significant
[13]. Similarly, our results demonstrate that antigenic escape can lead to the emergence of
compensatory mutations that push HA even further in antigenic space. These factors make it
difficult to infer the nature of selective pressures resulting in given HA sequence changes in
human IAV isolates.
Defining the specific properties of the HA molecule that facilitate mutational tolerance is
an area of intense study. Studies in vitro found that the HA globular head was highly tolerant
of both random substitutions and 5-amino acid block insertions [3,27,31,32]. These results
suggested that the HA globular head may exhibit a high degree of mutational robustness, such
that the median fitness effects of substitutions are relatively small [32–34]. Alternatively, muta-
tions may generally be costly, but are compensated by epistatic mutations that restore protein
function and fitness[6,35]. Our data, along with other studies that demonstrate fitness costs
associated with antigenic variation and/or rapid emergence of compensatory mutations fol-
lowing HA antigenic escape, suggest that compensatory epistatic interactions play a critical
role during antigenic drift [6,13,36,37].
Epistatic glycosylation
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If rapid compensation of antigenic escape mutations is important for maintaining fitness
during antigenic drift, then defining compensatory mechanisms is essential. Many antigenic-
ity-determining residues scattered in the HA globular domain also strongly influence avidity
and specificity for sialic acid receptors, and thus Ab escape substitutions at these residues can
negatively affect receptor interactions[13]. As a result, many of the compensatory mutations
that have been described in association with antigenic escape affect receptor interactions, and
likely serve to restore optimal receptor binding properties. The need to accumulate compensa-
tory mutations in order to combine antigenic novelty with fitness and transmissibility has
been proposed as an explanation for the discordance between the high in vitro mutation rates
and rapid Ab-based selection of influenza viruses in vivo and the relatively slow rates of popu-
lation-level antigenic evolution seen with influenza viruses[13,38]. Our results indicate that
glycosylation can play an important role in this process.
The availability of multiple mutational pathways to restore fitness increases the odds that a
fit variant will emerge under selection [39]. Our discovery that glycan addition beneficially
tunes receptor interactions adds to previously described mechanisms, including charge transi-
tions in the globular HA domain and alterations in NA activity [13,21,36,40]. While difficult to
test experimentally, it is intriguing to consider that IAV may have evolved to maximize the
number of compensatory pathways available during antigenic drift.
Our unexpected discovery of a new role for glycosylation in compensating for IAV immune
evasion highlights the power of virus population sequencing for uncovering novel mechanisms
of viral adaptation through high-definition forward genetics screening. The ability to accu-
rately measure changes in the viral population through methods such as primerID can provide
a comprehensive, unbiased profile of the genetic pathways to increased fitness under defined
selection conditions.
The primerID approach offers several advantages over conventional deep sequencing proto-
cols. First, the ability to generate a multi-read consensus of the original cDNA sequence reduces
the background nucleotide error rate from ~1% to ~0.01%, greatly increasing the sensitivity of
minor variant detection. In theory, this background represents the bona fide mutation fre-
quency within the population, combined with the mutation rate of the reverse transcriptase
used to generate the cDNA pool (~0.01%)[23]. Second, assembly of amplicon reads into ances-
tral cDNA sequences eliminates the distortion of measured variant frequencies by the stochastic
PCR re-sampling that occurs during conventional amplicon sequencing. Third, the number of
unique primerID barcodes used to generate consensus sequences represents the actual depth of
the viral population sequenced. Fourth, the ability to phase substitutions into authentic haplo-
types enables quantitation of linkage between substitutions within a given genome segment.
Finally, primerID requires far less virus input than other methods of highly accurate population
sequencing such as CirSeq, facilitating a wider range of experimental applications, including
the analysis of samples collected from infected animals or human subjects [41,42].
Altogether, we reveal a surprising new role for glycosylation in facilitating IAV immune
evasion by compensating for the fitness costs of antigenic escape mutations. These results
broaden our understanding of the critical function of glycosylation during antigenic drift and
shed light on the unique mutational plasticity of influenza HA. Further, these studies highlight
the remarkable potential of highly accurate virus population sequencing and high-definition
forward genetics for exploring viral evolution.
Materials and methods
Ethics
We obtained chicken eggs from a commercial vendor.
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Viruses
The original SV12 stock was generated as previously described [21], and passaged 2–3 times in
eggs in the absence of antibodies prior to RNA extraction and sequencing. We generated the
A/Puerto Rico/8/1934 (PR8) strain using the eight-plasmid rescue system (plasmids gener-
ously provided by Dr. Adolfo Garcia-Sastre; Icahn School of Medicine at Mt. Sinai, New
York). We generated seed virus by cotransfecting 293T cells (obtained from ATCC) with the
eight gene segment-encoding plasmids. Seed virus stocks were expanded once in 10-day-old
embryonated, specific pathogen-free (SPF) eggs. Allantoic fluid was collected 48 hours post
infection, and clarified by centrifugation. A reverse genetic construct expressing the consensus
HA gene segment sequence from SV12 was generated by RT-PCR amplification of the HA-
encoding segment from SV12 virions, and cloning it into the pDZ vector. Virus mutants were
generated by site-directed PCR mutagenesis of the relevant reverse genetics constructs. All
infectious virus titers were determined by end-point dilution on MDCK cells (obtained from
ATCC) in Gibco minimal essential medium (MEM) supplemented with 1 μg/mL trypsin
treated with l-(tosylamido-2-phenyl) ethyl chloromethyl ketone (TPCK-treated trypsin), 1mM
HEPES buffer (Corning), and gentamycin. TCID50 titers were determined using the Reed–
Muench method.
Comparison of viral growth kinetics
To compare peak titers of molecular clone-derived mutants, 500 TCID50 of each virus were
inoculated into 10 day old embryonated eggs in triplicate. Allantoic fluid was collected 48
hours post infection, and titers determined based on end-point dilution using MDCK cells as
described above.
HA glycan analysis
MCDK cells were infected with rSV12-HA and each molecular clone-derived mutant at an
MOI of 5 TCID50/cell. After 1 hour, virus supernatant was removed and replaced with Gibco
MEM supplemented with 7.5% fetal bovine serum, after washing cells with PBS containing
CaCl2 and MgCl2. Six hours post infection, cells were washed twice with PBS, and then
exposed to lysis buffer containing 1% sodium dodecyl sulfate, 50mM Tris-HCl pH 7.5, 10mM
dithiothreitol (DTT), 15U/mL DNase1, and mini-complete protease inhibitor. Lysate was then
digested either with EndoH or PNGase F or left untreated. Control or digested lysates were
then immunoblotted using the mouse HA2 chain specific mAb RA5-22[43].
Passaging experiments
Recombinant PR8 and SEQ12HA viruses were serially passaged three times in 10-day old
embryonated chicken eggs (Charles River) at a titer of 104 AOS ID/egg at 35˚C. At 16 hours
post infection, infected allantoic fluid was harvested, clarified and titrated using the AOS
method for the subsequent passage [44].
PrimerID library preparation
In experiments using recombinant viruses, hemagglutinin was sequenced using four overlap-
ping amplicons spanning the entire coding sequence. Viral RNA was extracted from allantoic
fluid using the QiaAmp Viral RNA Mini Kit. Viral RNA was reverse transcribed with Accu-
script Hi-Fi Reverse Transcriptase (Agilent) with the following primers bearing random
12-mer barcodes (All Ns hand-mixed to achieve ~25:25:25:25 ratio): PR8_SV12 Amp 1F 5’-
ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNNNNNNNCAGGAAAAT
Epistatic glycosylation
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006796 January 18, 2018 13 / 19
AAAAACAACCAAA ATG-3’, PR8_SV12 Amp 2F 5’-ACACTCTTTCCCTACACGACGC
TCTTCCGATCTNNNNNNNNNNNNCACCAAAGAAAGCTCATGGCCC-3’, PR8_SV12
Amp 3F 5’-ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNNNNNNNCAA
CACGAAGTGTCAAACACCC -3’, PR8_SV12 Amp 4F 5’-ACACTCTTTCCCTACACGAC
GCTCTTCCGATCTNNNNNNNNNNNNCAGGATTTCTGGACATTTGGAC -3’. The
reverse transcription reactions were purified using the PureLink PCR Purification kit (Invitro-
gen) using the high-molecular-weight cutoff buffer. First-round PCR was performed using
Platinum Taq DNA Polymerase High Fidelity (Invitrogen) with an estimated 105 copies of
cDNA templates, a universal forward primer (5’-AATGATACGGCGACCACCGAGATCTA
CACTCTTTCCCTACAC-3’) and amplicon-specific reverse primers: PR8_SV12 Amp 1R 5’-
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNATGGGAGCATGCTGCCG
TTA-3’, PR8_SV12 Amp 2R 5’-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNN
NGGGAGACTGCTGTTTATAGC-3’, PR8_SV12 Amp 3R 5’-GTGACTGGAGTTCAGACGT
GTGCTCTTCCGATCTNNNNCAGAGTCCTTTCATTTTCCA-3’, PR8_SV12 Amp 4R 5’-
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNATATCTCTGAAATTCTAA
TC-3’.
Sample indices were finally added using KAPA HiFi HotStart PCR Kit, 2.5μL of the first
round PCR products and indexed primers (5’- CAAGCAGAAGACGGCATACGAGAT(8-
mer sample ID)GTGACTGGAGTTCAGACGTGTG-3’). Amplicons were gel purified using
the Qiagen Gel Extraction Kit and quantified on a Nanodrop 1000. Amplicons were pooled
into a single library, quantified with the KAPA Library Quantification Kit, and sequenced
using the MiSeq Reagent Kit V3 with 325x325 paired-end cycles. The raw sequencing data is
available at the NCBI Short Read Archive under accession numbers SRR5428773-SRR5428801.
The primerID library preparation methods used for the original SV12 stock (Fig 2) differed
from the optimized pipeline described above in several substantive ways. A single amplicon
spanning HA amino acids 115 to 258 was generated using an RT primer with a random
10-mer barcode and the Superscript III RT enzyme (Thermo Fisher). Paired-end reads of the
amplicon did not overlap, leaving a gap involving codons 184–186. RT primer (HAF381):
ACACTCTTTCCCTACACGACGCTCTTCCGA TCTNNNNNNNNNNCAGCTAAGAG
AGCAATTGAGCTCAGTGTCATC. Reverse PCR primer HAr813: GTGACTGGAGTTCA
GACGTGTGCTCTTCCGATCTNNNN GATGCCGGACCCAAAGCCTCTACTCAGTGC.
Subsequent library preparation was as outlined above.
PrimerID data analysis
For the sequence analysis of passaging experiments using the recombinant PR8 and SV12
viruses, an optimized analysis pipeline was employed. In this pipeline, the first 4 bases of R2
reads were trimmed using fastx_trimmer from the FASTX Toolkit (v. 0.0.13; http://
hannonlab.cshl.edu/fastx_toolkit/). Overlapping paired-end reads were merged into a single
read using PANDAseq (v. 2.9)[45]. Merged reads were processed using filter_fastq_by_pri-
merid_length.pl to identify and extract the primerID from each read, with options—post CA
—removepost, and place the primerID sequence in the sequence id line for each read. Each
FASTQ file was split into separate amplicon libraries using Btrim64[46] with options -u 2 -v 2
-S -B -e 300; a list of primers for each amplicon was also supplied. Off-target sequences were
removed with get_majority_block_bam.pl, a wrapper script that maps the reads using BWA
MEM (v. 0.7.12-r1039[47] with options -B 1 -M, converts the output to BAM using Picard
SortSam (v. 1.130; http://broadinstitute.github.io/picard/), and retains only the reads that have
the most common mapped start and stop coordinates using BEDTools (v. 2.19.1)[48]. Reads
were collapsed into consensus sequences using merge_primerid_read_groups.pl with options
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—ambig 600—min_freq 0.75 to require that the consensus base called makes up at least 75%
of the bases for that position within the read group, otherwise an ambiguous base is called. The
minimum group size (-m) to use in the merging process was computed for each amplicon
within each sample (i.e., each library), using a formula derived for 12 bp primerID length,
based on the simulation model proposed by Zhou et al.[23] in order to reduce the effect of off-
spring primerID reads from large primerID groups on smaller primerID groups. (To derive
the formula for 12 bp primerIDs, the script consensus_cutoff.rb was run with length_of_pri-
mer_id set to 12.) If the computed minimum group size was less than 5, then -m was set to 5.
Consensus reads were converted to frequency tables for nucleotides, codons, and amino acids
at each position within the amplicon using convert_reads_to_amino_acid.pl.
Sequence analysis of the original SV12 stock library (Fig 2), generated using a slightly differ-
ent barcode primer design, substantively differed from the optimized analysis approach
described above as follows: PrimerID groups required a minimum of 2 reads, and the intra-
sample consensus was used as a tiebreaker.
To determine linkage between high frequency variants (MAF > 0.5%), we performed a
Fisher’s exact test for every pair of variants within each replicate and we derived a combined p-
value from these individual replicate p-values using Fisher’s method.
All software used for the optimized primerID analysis is available on Github: http://github.
com/niaid/primer-id-progs.
PrimerID-ViVan comparison. Libraries for the parental and passaged viruses were con-
structed as previously described. Briefly, full-length genomes were amplified from purified
viral RNA using a multisegment RT-PCR protocol[49]. Illumina libraries were then con-
structed using the Nextera XT DNA Library Prep Kit (Illumina) and sequenced on the Illu-
mina MiSeq platform according the manufacturer’s protocols. Variants for each library were
then called with the ViVan pipeline[24]. Variant frequencies were then compared between
primer ID and ViVan calls which passed filter.
Receptor binding analysis. We used Streptavidin Dip and Read Biosensors (ForteBIO,
Menlo Park, CA, USA) to measure binding of viruses to sialic acid. Graded amounts of bioti-
nylated 3’-Sialyl lactosamine PAA-biotin aka 3’SLN (GlykoTech) were captured on an avidin
coated biosensor. Virus binding experiments were performed by an Octet QKe biolayer inter-
ferometer (ForteBio). All of the viruses were diluted in PBS, pH = 7.4, 0.01% BSA, 0.002%
Tween-20, (kinetic buffer) for binding to 6’SLN to 1pM in presence of 10μM Oseltamivir
(ARC, St. Louis, Mo) and Zanamivir (Moravek Biochemicals, Brea,CA) to block viral NA
activity. Binding of virus was measured at 30˚C for 10 min followed by a 10 min dissociation
measurement.
Supporting information
S1 Fig. Variant calling comparison between ViVan and primerID methods. HA libraries
were prepared for both Nextera and amplicon sequencing, and analyzed with ViVan and Pri-
merID pipelines, respectively. Variant frequencies were compared between the final outputs of
both methods for parental wild-type and sequential 12 viruses (A and B) and all common vari-
ants in three replicates for passage 3 wild-type and sequential 12 viruses (C and D). Red line
indicates the expected 1:1 ratio.
(TIFF)
S2 Fig. Comparison of background variant frequency levels between ViVan and primerID
methods. (A, B) Combined minor amino acid variant frequency is shown for each position of
HA amplicon 2 region in SV12 parental sample for unmerged reads (before applying Pri-
merID), PrimerID consensus reads, and Nextera shotgun sequencing, evaluated by ViVan. (B)
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is a zoomed-in view of (A). (C, D) Fold enrichment of variant frequency over median variant
frequency for the amplicon region, shown for the same three methods in (A) and (B). (D) is a
zoomed-in view of (C).
(TIF)
S3 Fig. Non-reducing WB analysis of double glycan addition mutant. Immunoblot of puri-
fied virions as indicated electrophoresed under non-reducing conditions using the HA2 spe-
cific mAb RA5-22.
(TIFF)
S1 Table. PrimerID noise reduction.
(TIF)
S2 Table. Minor allele frequency background level in primerID and Nextera/ViVan
Sequencing.
(TIFF)
S3 Table. Pairwise amino acid variant combinations within primerID consensus reads of
the original SV12 stock. Variant amino acids were evaluated pairwise to determine the fre-
quency at which any two substitutions were observed in the same primerID consensus read.
The combined counts across the two biological replicates that were sequenced are listed for
each pairwise amino acid variant combination.
(TIFF)
S4 Table. Specific amino acid substitution combinations observed within primer ID conse-
sus reads in parental and passage 3 recombinant rSV12-HA populations. Each primerID
consensus read was assessed for its inferred amino acid identity at positions 133, 136, 144, 145,
and 225 (wild type at each position is NTKNG, respectively). The number of primerID conse-
sus reads that contained the indicated amino acid identities at these positions is listed. Variant
amino acids are highlighted in red, and combinations that contain two variant amino acids are
in bold face. This table only displays amino acid variant combinations that were observed in at
least two primerID concensus reads across all populations examined.
(TIFF)
S5 Table. Statistical assessment of linkage between high frequency amino acid substitu-
tions that emerged during rSV12-HA passage. Combined p-values from three replicate pop-
ulations as determined by Fisher’s method.
(TIFF)
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